Insider Selling: Milestone Scientific Inc. (NYSE:MLSS) Director Sells $15,600.00 in Stock

Milestone Scientific Inc. (NYSE:MLSS) Director Michael Mcgeehan sold 20,000 shares of the firm’s stock in a transaction on Thursday, December 19th. The shares were sold at an average price of $0.78, for a total value of $15,600.00. Following the sale, the director now directly owns 575,273 shares in the company, valued at approximately $448,712.94. This trade represents a 3.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Michael Mcgeehan also recently made the following trade(s):

• On Tuesday, September 24th, Michael Mcgeehan sold 209 shares of Milestone Scientific stock. The stock was sold at an average price of $1.00, for a total value of $209.00.

Milestone Scientific Stock Up 16.0 %

NYSE MLSS opened at $0.93 on Monday. The company has a market capitalization of $72.05 million, a price-to-earnings ratio of -13.21 and a beta of 1.10. Milestone Scientific Inc. has a twelve month low of $0.52 and a twelve month high of $1.10. The stock has a fifty day simple moving average of $0.81 and a 200 day simple moving average of $0.86.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on MLSS shares. Benchmark restated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th. StockNews.com started coverage on shares of Milestone Scientific in a report on Friday. They set a “hold” rating on the stock.

Institutional Investors Weigh In On Milestone Scientific

A number of institutional investors have recently made changes to their positions in the stock. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific during the third quarter worth about $48,000. Geode Capital Management LLC increased its position in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Finally, World Investment Advisors LLC bought a new position in Milestone Scientific during the 3rd quarter worth approximately $91,000. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.